Association Between Uric Acid to HDL Cholesterol Ratio and Diabetic Complications in Men and Postmenopausal Women

References

• Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14:88–98. doi:10.1038/nrendo.2017.151
   PubMed Web of Science ®Google Scholar
• Cho NH, Shaw JE, Karuranga S, et al. IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271–281. doi:10.1016/j.diabres.2018.02.023
   PubMed Web of Science ®Google Scholar
• Price HI, Agnew MD, Gamble JM. Comparative cardiovascular morbidity and mortality in patients taking different insulin regimens for type 2 diabetes: a systematic review. BMJ Open. 2015;5:e006341. doi:10.1136/bmjopen-2014-006341
   PubMed Web of Science ®Google Scholar
• Wang T, Lu J, Shi L, et al. Association of insulin resistance and beta-cell dysfunction with incident diabetes among adults in China: a nationwide, population-based, prospective cohort study. Lancet Diabetes Endocrinol. 2020;8:115–124. doi:10.1016/S2213-8587(19)30425-5
   PubMed Web of Science ®Google Scholar
• Fenech G, Rajzbaum G, Mazighi M, et al. Serum uric acid and cardiovascular risk: state of the art and perspectives. Joint Bone Spine. 2014;81:392–397. doi:10.1016/j.jbspin.2014.01.008
   PubMed Web of Science ®Google Scholar
• Katsiki N, Dimitriadis GD, Mikhailidis DP. Serum uric acid and diabetes: from pathophysiology to cardiovascular disease. Curr Pharm Des. 2021;27:1941–1951. doi:10.2174/1381612827666210104124320
   PubMed Web of Science ®Google Scholar
• Lee SW, Kim HC, Nam C, et al. Age-differential association between serum uric acid and incident hypertension. Hypertens Res. 2019;42:428–437. doi:10.1038/s41440-018-0168-4
   PubMed Web of Science ®Google Scholar
• Wan H, Wang Y, Chen Y, et al. Different associations between serum urate and diabetic complications in men and postmenopausal women. Diabetes Res Clin Pract. 2020;160:108005.
   PubMed Web of Science ®Google Scholar
• Chen D, Sun X, Zhao X, et al. Associations of serum uric acid and urinary albumin with the severity of diabetic retinopathy in individuals with type 2 diabetes. BMC Ophthalmol. 2020;20:467.
   PubMed Web of Science ®Google Scholar
• Grassi D, Ferri L, Desideri G, et al. Chronic hyperuricemia, uric acid deposit and cardiovascular risk. Curr Pharm Des. 2013;19:2432–2438. doi:10.2174/1381612811319130011
   PubMed Web of Science ®Google Scholar
• Li X, Meng X, Timofeeva M, et al. Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies. BMJ. 2017;357:j2376. doi:10.1136/bmj.j2376
   PubMed Web of Science ®Google Scholar
• Ioannou GN, Boyko EJ. Effects of menopause and hormone replacement therapy on the associations of hyperuricemia with mortality. Atherosclerosis. 2013;226:220–227. doi:10.1016/j.atherosclerosis.2012.10.044
   PubMed Web of Science ®Google Scholar
• Du P, Zhang B, Wang HJ, et al. The prevalence and secular trends of abdominal obesity among Chinese adults, 1993-2011. Ann Epidemiol. 2015;25:797–799. doi:10.1016/j.annepidem.2015.06.082
   PubMed Web of Science ®Google Scholar
• Nakhjavani M, Imani M, Larry M, et al. Metabolic syndrome in premenopausal and postmenopausal women with type 2 diabetes: loss of protective effects of premenopausal status. J Diabetes Metab Disord. 2014;13:102.
   PubMedGoogle Scholar
• Lejskova M, Alusik S, Valenta Z, et al. Natural postmenopause is associated with an increase in combined cardiovascular risk factors. Physiol Res. 2012;61:587–596. doi:10.33549/physiolres.932313
   PubMed Web of Science ®Google Scholar
• Castro-Barquero S, Ruiz-Leon AM, Sierra-Perez M, et al. Dietary strategies for metabolic syndrome: a comprehensive review. Nutrients. 2020;12:2983. doi:10.3390/nu12102983
   PubMedGoogle Scholar
• Hopkins AL, Lamm MG, Funk JL, et al. Hibiscus sabdariffa L. in the treatment of hypertension and hyperlipidemia: a comprehensive review of animal and human studies. Fitoterapia. 2013;85:84–94. doi:10.1016/j.fitote.2013.01.003
   PubMed Web of Science ®Google Scholar
• Hoy SM. Pitavastatin: a review in hypercholesterolemia. Am J Cardiovasc Drugs. 2017;17:157–168. doi:10.1007/s40256-017-0213-8
   PubMed Web of Science ®Google Scholar
• Athyros VG, Doumas M, Imprialos KP, et al. Diabetes and lipid metabolism. Hormones. 2018;17:61–67. doi:10.1007/s42000-018-0014-8
   PubMedGoogle Scholar
• Wong NKP, Nicholls SJ, Tan JTM, et al. The role of high-density lipoproteins in diabetes and its vascular complications. Int J Mol Sci. 2018;19:1680. doi:10.3390/ijms19061680
   PubMed Web of Science ®Google Scholar
• Aktas G, Kocak MZ, Bilgin S, et al. Uric acid to HDL cholesterol ratio is a strong predictor of diabetic control in men with type 2 diabetes mellitus. Aging Male. 2020;23:1098–1102. doi:10.1080/13685538.2019.1678126
   PubMed Web of Science ®Google Scholar
• Aktas G, Khalid A, Kurtkulagi O, et al. Poorly controlled hypertension is associated with elevated serum uric acid to HDL-cholesterol ratio: a cross-sectional cohort study. Postgrad Med. 2022;134:297–302. doi:10.1080/00325481.2022.2039007
   PubMed Web of Science ®Google Scholar
• Kurtkulagi O, Tel BMA, Kahveci G, et al. Hashimoto’s thyroiditis is associated with elevated serum uric acid to high density lipoprotein-cholesterol ratio. Rom J Intern Med. 2021;59:403–408. doi:10.2478/rjim-2021-0023
   PubMed Web of Science ®Google Scholar
• Kosekli MA, Kurtkulagii O, Kahveci G, et al. The association between serum uric acid to high density lipoprotein-cholesterol ratio and non-alcoholic fatty liver disease: the abund study. Rev Assoc Med Bras. 1992;67:549–554.
   Google Scholar
• Kocak MZ, Aktas G, Erkus E, et al. Neuregulin-4 is associated with plasma glucose and increased risk of type 2 diabetes mellitus. Swiss Med Wkly. 2019;149:w20139. doi:10.4414/smw.2019.20139
   PubMed Web of Science ®Google Scholar
• Kocak MZ, Aktas G, Atak BM, et al. Is Neuregulin-4 a predictive marker of microvascular complications in type 2 diabetes mellitus? Eur J Clin Invest. 2020;50:e13206. doi:10.1111/eci.13206
   PubMed Web of Science ®Google Scholar
• Chen LL, Peng MM, Zhang JY, et al. Elevated circulating Neuregulin4 level in patients with diabetes. Diabetes Metab Res Rev. 2017;33:e2870. doi:10.1002/dmrr.2870
   Web of Science ®Google Scholar
• Yazdi F, Baghaei MH, Baniasad A, et al. Investigating the relationship between serum uric acid to high-density lipoprotein ratio and metabolic syndrome. Endocrinol Diabetes Metab. 2022;5:e00311. doi:10.1002/edm2.311
   PubMedGoogle Scholar
• Zhang YN, Wang QQ, Chen YS, et al. Association between serum uric acid to HDL-cholesterol ratio and nonalcoholic fatty liver disease in lean Chinese adults. Int J Endocrinol. 2020;2020:5953461.
   PubMed Web of Science ®Google Scholar
• Kocak MZ, Aktas G, Erkus E, et al. Serum uric acid to HDL-cholesterol ratio is a strong predictor of metabolic syndrome in type 2 diabetes mellitus. Rev Assoc Med Bras. 1992;65:9–15.
   Google Scholar
• Wang Y, Zhang W, Xia F, et al. Moderation effect of economic status in the association between early life famine exposure and MAFLD in adulthood. Liver Int. 2021;2021:5.
   Google Scholar
• Wan H, Wang Y, Xiang Q, et al. Associations between abdominal obesity indices and diabetic complications: Chinese visceral adiposity index and neck circumference. Cardiovasc Diabetol. 2020;19:118.
   PubMed Web of Science ®Google Scholar
• Wang N, Chen Y, Ning Z, et al. Exposure to famine in early life and nonalcoholic fatty liver disease in adulthood. J Clin Endocrinol Metab. 2016;101:2218–2225. doi:10.1210/jc.2016-1076
   PubMed Web of Science ®Google Scholar
• Ning Z, Zhang K, Zhao L, et al. Exacerbation of liver steatosis following exposure to famine and overnutrition. Mol Nutr Food Res. 2017;61. DOI:10.1002/mnfr.201700097
   Web of Science ®Google Scholar
• Pan XF, Wang L, Pan A. Epidemiology and determinants of obesity in China. Lancet Diabetes Endocrinol. 2021;9:373–392. doi:10.1016/S2213-8587(21)00045-0
   PubMed Web of Science ®Google Scholar
• Xu Y, Wang L, He J, et al. Prevalence and control of diabetes in Chinese adults. JAMA. 2013;310:948–959. doi:10.1001/jama.2013.168118
   PubMed Web of Science ®Google Scholar
• Qi H, Hu C, Wang S, et al. Early life famine exposure, adulthood obesity patterns and the risk of nonalcoholic fatty liver disease. Liver Int. 2020;40:2694–2705. doi:10.1111/liv.14572
   PubMed Web of Science ®Google Scholar
• Ji H, Zhang H, Xiong J, et al. eGFRs from Asian-modified CKD-EPI and Chinese-modified CKD-EPI equations were associated better with hypertensive target organ damage in the community-dwelling elderly Chinese: the Northern Shanghai Study. Clin Interv Aging. 2017;12:1297–1308. doi:10.2147/CIA.S141102
   PubMed Web of Science ®Google Scholar
• Authors/Task Force M, Guidelines ESCCfP, Societies ESCNC. ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Atherosclerosis. 2019;290:140–205.
   PubMed Web of Science ®Google Scholar
• Wu L, Fernandez-Loaiza P, Sauma J, et al. Classification of diabetic retinopathy and diabetic macular edema. World J Diabetes. 2013;4:290–294. doi:10.4239/wjd.v4.i6.290
   PubMedGoogle Scholar
• Ndrepepa G. Uric acid and cardiovascular disease. Clin Chim Acta. 2018;484:150–163. doi:10.1016/j.cca.2018.05.046
   PubMed Web of Science ®Google Scholar
• Chang DY, Wang JW, Chen M, et al. Association between serum uric acid level and mortality in China. Chin Med J. 2021;134:2073–2080. doi:10.1097/CM9.0000000000001631
   PubMed Web of Science ®Google Scholar
• Zalawadiya SK, Veeranna V, Mallikethi-Reddy S, et al. Uric acid and cardiovascular disease risk reclassification: findings from NHANES III. Eur J Prev Cardiol. 2015;22:513–518. doi:10.1177/2047487313519346
   PubMed Web of Science ®Google Scholar
• Rader DJ, Hovingh GK. HDL and cardiovascular disease. Lancet. 2014;384(9943):618–625. doi:10.1016/S0140-6736(14)61217-4
   PubMed Web of Science ®Google Scholar
• Ahmed HM, Miller M, Nasir K, et al. Primary low level of high-density lipoprotein cholesterol and risks of coronary heart disease, cardiovascular disease, and death: results from the multi-ethnic study of atherosclerosis. Am J Epidemiol. 2016;183:875–883. doi:10.1093/aje/kwv305
   PubMed Web of Science ®Google Scholar
• Kaze AD, Santhanam P, Musani SK, et al. Metabolic dyslipidemia and cardiovascular outcomes in type 2 diabetes mellitus: findings from the look AHEAD study. J Am Heart Assoc. 2021;10:e016947. doi:10.1161/JAHA.120.016947
   PubMed Web of Science ®Google Scholar
• Kostara CE, Ferrannini E, Bairaktari ET, et al. Early signs of atherogenic features in the HDL lipidomes of normolipidemic patients newly diagnosed with type 2 diabetes. Int J Mol Sci. 2020;21:8835. doi:10.3390/ijms21228835
   PubMed Web of Science ®Google Scholar
• Cheatham CL, Vazquez-Vidal I, Medlin A, et al. Blueberry consumption affects serum uric acid concentrations in older adults in a sex-specific manner. Antioxidants. 2016;29:43. doi:10.3390/antiox5040043
   Google Scholar
• De Cosmo S, Viazzi F, Pacilli A, et al. Serum uric acid and risk of CKD in type 2 diabetes. Clin J Am Soc Nephrol. 2015;10:1921–1929. doi:10.2215/CJN.03140315
   PubMed Web of Science ®Google Scholar
• Xu Y, Zhu J, Gao L, et al. Hyperuricemia as an independent predictor of vascular complications and mortality in type 2 diabetes patients: a meta-analysis. PLoS One. 2013;8:e78206. doi:10.1371/journal.pone.0078206
   PubMed Web of Science ®Google Scholar
• Russo GT, De Cosmo S, Viazzi F, et al. Plasma triglycerides and HDL-C levels predict the development of diabetic kidney disease in subjects with type 2 diabetes: the AMD annals initiative. Diabetes Care. 2016;39:2278–2287. doi:10.2337/dc16-1246
   PubMed Web of Science ®Google Scholar
• Cai X, Chen Y, Yang W, et al. The association of smoking and risk of diabetic retinopathy in patients with type 1 and type 2 diabetes: a meta-analysis. Endocrine. 2018;62:299–306. doi:10.1007/s12020-018-1697-y
   PubMed Web of Science ®Google Scholar
• Morton J, Zoungas S, Li Q, et al. Low HDL cholesterol and the risk of diabetic nephropathy and retinopathy: results of the ADVANCE study. Diabetes Care. 2012;35:2201–2206. doi:10.2337/dc12-0306
   PubMed Web of Science ®Google Scholar